105 results
Page 2 of 6
8-K
pur2pb5b9
18 May 23
Regulation FD Disclosure
3:24pm
8-K
EX-99.1
q9rg k73sp
18 May 23
Regulation FD Disclosure
3:24pm
8-K
EX-99.1
r3qe9z
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
8-K
EX-99.1
7g1 2anqm
14 Dec 22
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
11:22am
8-K
EX-99.2
3ty0ti
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
24datoayq
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
chd v52dym
4 Nov 22
Other Events
11:24am
8-K
EX-99.1
vmtkj
4 Aug 22
Regulation FD Disclosure
9:30am
8-K
EX-10.1
69ps2d nmbbtf
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
mo8lf4qj5plncyz7vw
26 Jan 22
Processa Pharmaceuticals CEO Dr. David Young Issues Letter to Shareholders Providing Outlook for 2022
8:15am